IL17A and psoriasis: Kim CH et al. [119] established a mouse model of IMQ-induced psoriasis and found that hE-MSCs inhibited the expression of Th17-cell-related factors (IL-17 and IL-23) and implemented immunomodulation to psoriasis, which may be a key factor in improving psoriasis.